|
|||||
|
|
Combination therapy – deferasirox and deferoxamine – in thalassemia major patients in emerging countries with limited resources |
|
| Authors: | N. Arandi S. Haghpanah S. Safaei Z. Zahedi A. Ashrafi P. Eatemadfar T. Zarei A. H Radwan A. T Taher M. Karimi |
| Affiliation: | 1. Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran;2. Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon |
| Abstract: | |
| Keywords: | β ‐Thalassemia chelation therapy deferasirox deferoxamine serum ferritin |